Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
Tarsus Pharmaceuticals (NASDAQ: TARS) has scheduled its second quarter 2025 financial results announcement and corporate update for Wednesday, August 6, 2025. The company will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET. Following the live presentation, a recorded version will be available on the company's website and remain accessible for approximately 90 days.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 e un aggiornamento aziendale per mercoled矛 6 agosto 2025. La societ脿 terr脿 una diretta webcast alle 13:30 PT / 16:30 ET. Dopo la presentazione dal vivo, una registrazione sar脿 disponibile sul sito web dell'azienda e rester脿 accessibile per circa 90 giorni.
Tarsus Pharmaceuticals (NASDAQ: TARS) ha programado el anuncio de resultados financieros del segundo trimestre de 2025 y una actualizaci贸n corporativa para el mi茅rcoles 6 de agosto de 2025. La compa帽铆a realizar谩 una transmisi贸n en vivo a las 1:30 p.m. PT / 4:30 p.m. ET. Despu茅s de la presentaci贸n en vivo, una versi贸n grabada estar谩 disponible en el sitio web de la empresa y permanecer谩 accesible por aproximadamente 90 d铆as.
Tarsus Pharmaceuticals (NASDAQ: TARS)電� 2025雲� 2攵勱赴 鞛 鞁れ爜 氚滍憸 氚� 須岇偓 鞐呺嵃鞚错姼毳� 2025雲� 8鞗� 6鞚� 靾橃殧鞚�鞐� 鞓堨爼頄堨姷雼堧嫟. 須岇偓電� 鞓ろ泟 1:30 PT / 鞓ろ泟 4:30 ET鞐� 霛检澊敫� 鞗轨簮鞀ろ姼毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 霛检澊敫� 氚滍憸 頉� 雲鬼檾霅� 氩勳爠鞚� 須岇偓 鞗轨偓鞚错姼鞐� 瓴岇嫓霅橂┌ 鞎� 90鞚缄皠 鞚挫毄頃� 靾� 鞛堨姷雼堧嫟.
Tarsus Pharmaceuticals (NASDAQ : TARS) a programm茅 l'annonce des r茅sultats financiers du deuxi猫me trimestre 2025 et une mise 脿 jour de l'entreprise pour le mercredi 6 ao没t 2025. La soci茅t茅 organisera une webdiffusion en direct 脿 13h30 PT / 16h30 ET. Apr猫s la pr茅sentation en direct, une version enregistr茅e sera disponible sur le site web de l'entreprise et restera accessible pendant environ 90 jours.
Tarsus Pharmaceuticals (NASDAQ: TARS) hat die Bekanntgabe der Finanzergebnisse f眉r das zweite Quartal 2025 und ein Unternehmensupdate f眉r Mittwoch, den 6. August 2025 geplant. Das Unternehmen wird eine Live-Webcast um 13:30 Uhr PT / 16:30 Uhr ET veranstalten. Nach der Live-Pr盲sentation wird eine Aufzeichnung auf der Website des Unternehmens verf眉gbar sein und etwa 90 Tage zug盲nglich bleiben.
- None.
- None.
IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its second quarter 2025 financial results and provide a corporate update.
Participants may access the webcast . A recorded version of the call will be available on the website shortly after the completion of the webcast and will be archived there for approximately 90 days.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY庐聽(lotilaner ophthalmic solution)
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
FAQ
When will Tarsus Pharmaceuticals (TARS) report Q2 2025 earnings?
How can investors access the Tarsus Pharmaceuticals Q2 2025 earnings call?
How long will the Tarsus Pharmaceuticals Q2 2025 earnings call recording be available?
What will be discussed during the Tarsus Pharmaceuticals August 6 webcast?
